As the F.D.A. considers a new Alzheimer’s medication, we asked experts how the rollout of a similar drug has gone.
Young-onset Alzheimer’s is more heritable than late-onset Alzheimer’s: “If somebody has developed Alzheimer’s disease at an ...
These statistics amplify the remarkable and noteworthy nature of Nicholls's achievement in reversing his symptoms of ...
Nicholls and Zerbe arguably did "reverse" their symptoms of Alzheimer's. This is because conditions such as obesity, ...
Cassava Sciences is advancing simufilam, amid scrutiny over data integrity and trial conduct. Check out the reasons why SAVA ...
A new study shows how targeting the Plexin-B1 protein can stop or decrease the progression speed of Alzheimer's disease.
A woman and a man living with Alzheimer’s have reportedly been able to halt and, to some degree, “reverse” the effects of ...
Scientists may be one step closer to a cure for Alzheimer’s after working out who is most likely to get the disease. Researchers have discovered almost all individuals with two copies of a particular ...
In a new paper in "Nature Medicine," an international team of neurologists makes the compelling case that people with two copies of a gene called APOE4 aren’t just at risk of Alzheimer’s ...
SALT LAKE CITY — Having two copies of a gene long believed to increase the risk of Alzheimer's disease may actually be a ... age 65 with two copies of the APOE4 gene show biological ...
In a new paper in "Nature Medicine," an international team of neurologists makes the compelling case that people with two copies of a gene called APOE4 aren’t just at risk of Alzheimer’s ...
In a new paper in "Nature Medicine," an international team of neurologists makes the compelling case that people with two copies of a gene called APOE4 aren’t just at risk of Alzheimer’s ...